BMV:FBT - 1ST TR EXCHANGE/NYSE ARCA BIOTECHNO Stock Price, News, & Analysis

1ST TR EXCHANGE/NYSE ARCA BIOTECHNO trades on the BMV under the ticker symbol "FBT."

Media stories about FBT stock have been trending very positive on Tuesday, InfoTrie reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. 1ST TR EXCHANGE/NYSE ARCA BIOTECHNO earned a media sentiment score of 3.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

1ST TR EXCHANGE/NYSE ARCA BIOTECHNO's stock is owned by a variety of of institutional and retail investors. Top institutional investors include O Dell Group LLC (0.00%), RPG Investment Advisory LLC (0.00%), Steward Partners Investment Advisory LLC (0.00%), Juncture Wealth Strategies LLC (0.00%), Dorsey Wright & Associates (0.00%) and PFG Advisors (0.00%).

FBT stock was sold by a variety of institutional investors in the last quarter, including Juncture Wealth Strategies LLC, O Dell Group LLC, Dorsey Wright & Associates, Intl Fcstone Inc. and RPG Investment Advisory LLC.

FBT stock was purchased by a variety of institutional investors in the last quarter, including Steward Partners Investment Advisory LLC, PFG Advisors, Arlington Financial Advisors LLC, Vanguard Capital Wealth Advisors and Bogart Wealth LLC.

Shares of FBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of FBT stock can currently be purchased for approximately $144.28.